SCHEMBL7966975

SCHEMBL7966975

COc1cc(C(=O)N(C)c2ccc(C)cc2OCCCCCC(=O)N2CCN(C)CC2)ccc1C(=O)Nc1cccc2[nH]c(CN3CCOCC3)nc12

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.35
NPC1 O15118 1/20 0.35
GLA P06280 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
CD274 Q9NZQ7 2/20 0.35
LMNA P02545 2/20 0.35
ALDH1A1 P00352 1/20 0.35
PDCD1 Q15116 1/20 0.35
GAA P10253 2/20 0.34
MAPK14 Q16539 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
DYRK1A Q13627 1/20 0.34
KDR P35968 2/20 0.33
EGFR P00533 1/20 0.33
HDAC1 Q13547 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7978179 0.99 KDM4E (0.35) KDM4ENPC1GLAHPGDRAB9A
SCHEMBL7430655 0.96 MAP3K7 (0.34) KDREGFRHDAC1
Hydrochloric Acid SCHEMBL7964462 0.95 MAP3K7 (0.34) KDREGFRHDAC1
SCHEMBL7967134 0.95 AVPR2 (0.35) LMNAALDH1A1HDAC1
SCHEMBL7954419 0.94 AVPR2 (0.35) LMNAALDH1A1KDRHDAC1
Hydrochloric Acid SCHEMBL7970772 0.94 AVPR2 (0.35) LMNAALDH1A1HDAC1
Hydrochloric Acid SCHEMBL7962024 0.94 AVPR2 (0.35) LMNAALDH1A1KDRHDAC1
SCHEMBL7485533 0.93 IRAK4 (0.37) KDM4ENPC1GLAHPGDRAB9A
SCHEMBL7966971 0.93 CD274 (0.34) CD274LMNAALDH1A1PDCD1MAPK14
Hydrochloric Acid SCHEMBL7969811 0.93 IRAK4 (0.37) KDM4ENPC1GLAHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed